Haffkine Bio-Pharmaceutical Corporation Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 8.71 Cr
- Company Age 50 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 47.95 Cr
- Satisfied Charges ₹ 129.19 Cr
- Revenue Growth 56.97%
- Profit Growth 31.48%
- Ebitda 48.90%
- Net Worth -9.68%
- Total Assets -5.30%
About Haffkine Bio-Pharmaceutical Corporation
Haffkine Bio-Pharmaceutical Corporation Limited (HBCL) is a leading Private Limited State Government Company incorporated in India on 28 March 1974 and has a history of 50 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.71 Cr.
The company currently has active open charges totaling ₹47.95 Cr. The company has closed loans amounting to ₹129.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Karanjkar, Deepak Pednekar, Dimple Kasana, and Four other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1974SGC017341
- Company No.
017341
- Company Classification
Private Limited State Government Company
- Incorporation Date
28 Mar 1974
- Date of AGM
30 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Haffkine Bio-Pharmaceutical Corporation?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Vyas  | Managing Director | 01-Oct-2020 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Pednekar | Director | 28-Jan-2021 | Current |
| Ashok Karanjkar | Director | 10-Aug-2022 | Current |
| Dimple Kasana | Director | 17-Oct-2021 | Current |
| Deelip Mhaisekar | Director | 05-Jul-2021 | Current |
| Mary Kerketta | Director | 01-Jan-2021 | Current |
| Saurabh Vijay | Director | 27-Jul-2020 | Current |
Financial Performance of Haffkine Bio-Pharmaceutical Corporation.
Haffkine Bio-Pharmaceutical Corporation Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.97% increase. The company also saw a substantial improvement in profitability, with a 31.48% increase in profit. The company's net worth dipped by a decrease of 9.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Haffkine Bio-Pharmaceutical Corporation?
In 2022, Haffkine Bio-Pharmaceutical Corporation had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Paithan Mega Food Park Private LimitedAshok Karanjkar is a mutual person
Nashik Municipal Smart City Development Corporation LimitedAshok Karanjkar is a mutual person
Maharashtra Information Technology Corporation LimitedSaurabh Vijay is a mutual person
Nashik Mahanagar Parivahan Mahamandal LimitedAshok Karanjkar is a mutual person
- Maha Arc Limited
Saurabh Vijay is a mutual person
- Maharashtra State Faculty Development Academy
Saurabh Vijay is a mutual person
Charges (Loans)
₹47.95 Cr
₹129.19 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 47.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 1997 | Canara Bank | ₹47.95 Cr | Open |
| 03 Oct 2007 | Canara Bank | ₹20.00 Cr | Satisfied |
| 31 Oct 2002 | Canara Bank | ₹14.25 Cr | Satisfied |
| 21 Oct 2002 | Canara Bank | ₹2.73 Cr | Satisfied |
| 24 Apr 2002 | Canara Bank | ₹7.27 M | Satisfied |
How Many Employees Work at Haffkine Bio-Pharmaceutical Corporation?
Haffkine Bio-Pharmaceutical Corporation has a workforce of 273 employees as of Oct 17, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Haffkine Bio-Pharmaceutical Corporation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haffkine Bio-Pharmaceutical Corporation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
